Literature DB >> 15598213

Gene expression profile analysis in human T lymphocytes from patients with Down Syndrome.

S Giannone1, P Strippoli, L Vitale, R Casadei, S Canaider, L Lenzi, P D'Addabbo, F Frabetti, F Facchin, A Farina, P Carinci, M Zannotti.   

Abstract

Down Syndrome (DS) is caused by the presence of three copies of the whole human chromosome 21 (HC21) or of a HC21 restricted region; the phenotype is likely to have originated from the altered expression of genes in the HC21. We apply the cDNA microarray method to the study of gene expression in human T lymphocytes with trisomy 21 in comparison to normal cells. Two patients with DS were investigated, along with two normal subjects as a control, all being tested in independent, duplicated cell culture experiments. The most consistent finding was the overexpression of the superoxide dismutase gene (SOD1), located on 21q, and of MHC DR beta 3 (HLA-DRB3), GABA receptor A gamma 2 (GABRG2), acetyltransferase Coenzyme, A 2 (ACAT2) and ras suppressor protein 1 (RSU1) genes. When the data were clustered according to chromosome localization, the HC21 gene set showed, on average, the highest expression in DS cells in all the experiments. Moreover, separate clustering of patients and controls was obtained when analysis was restricted to HC21 gene expression values. These findings reinforce the specific gene dosage theory for the pathogenesis of the DS phenotype, and show a consistent overexpression of the SOD1 gene on 21q.

Entities:  

Mesh:

Year:  2004        PMID: 15598213     DOI: 10.1046/j.1529-8817.2003.00123.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  17 in total

1.  Exon Array Biomarkers for the Differential Diagnosis of Schizophrenia and Bipolar Disorder.

Authors:  Marquis Philip Vawter; Robert Philibert; Brandi Rollins; Patricia L Ruppel; Terry W Osborn
Journal:  Mol Neuropsychiatry       Date:  2018-04-10

2.  Gene expression variation increase in trisomy 21 tissues.

Authors:  Ching Yu Chou; Li Yu Liu; Chien Yu Chen; Cheng Hsien Tsai; Hsiao Lin Hwa; Li Yun Chang; Yi Shing Lin; Fon Jou Hsieh
Journal:  Mamm Genome       Date:  2008-07-02       Impact factor: 2.957

3.  Co-expression network analysis of Down's syndrome based on microarray data.

Authors:  Jianping Zhao; Zhengguo Zhang; Shumin Ren; Yanan Zong; Xiangdong Kong
Journal:  Exp Ther Med       Date:  2016-06-17       Impact factor: 2.447

4.  Altered DNA methylation in leukocytes with trisomy 21.

Authors:  Kristi Kerkel; Nicole Schupf; Kota Hatta; Deborah Pang; Martha Salas; Alexander Kratz; Mark Minden; Vundavalli Murty; Warren B Zigman; Richard P Mayeux; Edmund C Jenkins; Ali Torkamani; Nicholas J Schork; Wayne Silverman; B Anne Croy; Benjamin Tycko
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

5.  A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells.

Authors:  Anita Bhattacharyya; Erin McMillan; Serene I Chen; Kyle Wallace; Clive N Svendsen
Journal:  Dev Neurosci       Date:  2009-09-09       Impact factor: 2.984

6.  Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes.

Authors:  E Aït Yahya-Graison; J Aubert; L Dauphinot; I Rivals; M Prieur; G Golfier; J Rossier; L Personnaz; N Creau; H Bléhaut; S Robin; J M Delabar; M-C Potier
Journal:  Am J Hum Genet       Date:  2007-07-19       Impact factor: 11.025

7.  Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart.

Authors:  Rong Mao; Xiaowen Wang; Edward L Spitznagel; Laurence P Frelin; Jason C Ting; Huashi Ding; Jung-whan Kim; Ingo Ruczinski; Thomas J Downey; Jonathan Pevsner
Journal:  Genome Biol       Date:  2005-12-16       Impact factor: 13.583

8.  Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.

Authors:  Chong Li; Lei Jin; Yun Bai; Qimin Chen; Lijun Fu; Minjun Yang; Huasheng Xiao; Guoping Zhao; Shengyue Wang
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

9.  Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.

Authors:  Julien Laffaire; Isabelle Rivals; Luce Dauphinot; Fabien Pasteau; Rosine Wehrle; Benoit Larrat; Tania Vitalis; Randal X Moldrich; Jean Rossier; Ralph Sinkus; Yann Herault; Isabelle Dusart; Marie-Claude Potier
Journal:  BMC Genomics       Date:  2009-03-30       Impact factor: 3.969

10.  Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy.

Authors:  Anna Conti; Floriana Fabbrini; Paola D'Agostino; Rosa Negri; Dario Greco; Rita Genesio; Maria D'Armiento; Carlo Olla; Dario Paladini; Mariastella Zannini; Lucio Nitsch
Journal:  BMC Genomics       Date:  2007-08-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.